ASX/NYR (ASX/NYR)

Australian Securities Exchange: ASX/NYR · AUD

A$0.49

-0.00 (-1.0%)· Recorded snapshot

Market cap	121.3M
Revenue (ttm)	2M
Net income (ttm)	-6.6M
EPS (ttm)	-A$0.03
Shares out	247.6M
Volume	121,948
Beta	1.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2M
Net income (ttm): -6.6M
EPS (ttm): -A$0.03
Market cap: 121.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-100

P25 -108P50 -50.6P75 1.1

ROIC-64.2

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/NYR indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

AUD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	United States
Country code	AU
Earnings date	2026-08-21
Enterprise value	AUD 112.9M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2017
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000070195
Last earnings date	2026-02-17
Last refreshed	2026-10-29
Market cap	AUD 121.3M
Price	AUD 0.49
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	asx/NYR
Website	https://www.nyrada.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-5.6%
EV/Sales	56.15x
FCF / EV yield	-4%
FCF yield	-3.73%
Industry forward P/E	28.82x
P/B ratio	12.71x
P/S ratio	60.32x
Price / tangible book value	12.75x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-59.62%
Operating margin	-335.07%
Pretax margin	-326.01%
ROA	-53.59%
ROA (5Y)	-40.59%
ROCE	-70.56%
ROE	-99.95%
ROE (5Y)	-74.28%
ROIC	-64.21%
SBC / revenue	125.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	-16.08%
Revenue growth (Q)	-23.01%
Revenue growth (QoQ)	57.74%
Revenue growth 3Y	12.05%
Revenue growth 5Y	-2.95%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -9,845
Depreciation and amortization	AUD 3,211
EBIT	AUD -6.7M
EBITDA	AUD -6.7M
EPS	AUD -0.03
FCF per share	AUD -0.02
Financing cash flow	AUD 10M
Free cash flow	AUD -4.5M
Free cash flow minus SBC	AUD -7M
Gross profit	AUD -1.2M
Investing cash flow	AUD -9,845
Net cash flow	AUD 5.5M
Net income	AUD -6.6M
Operating cash flow minus SBC	AUD -7M
Operating income	AUD -6.7M
Revenue	AUD 2M
Stock-based compensation	AUD 2.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	86.37
Book value per share	AUD 0.04
Debt / equity	0
Long-term assets	AUD 35,770
Long-term liabilities	AUD 7,432
Net cash (debt)	AUD 8.4M
Net cash / market cap	6.91%
Net cash growth	186.1%
Net debt / equity	-0.88
Piotroski F-Score	3
Property, plant and equipment	AUD 9,018
Shareholders' equity	AUD 9.5M
Tangible book value	AUD 9.5M
Tangible book value per share	AUD 0.04
Total assets	AUD 10.4M
Total cash	AUD 8.4M
Total debt	AUD 0
Total liabilities	AUD 877,286
WACC	9.91%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.26
Current assets	AUD 10.4M
Current liabilities	AUD 869,854
Current ratio	11.94
Net working capital	AUD 1.1M
Quick ratio	11.7
Working capital	AUD 9.5M
Working capital turnover	0.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-19.45%
Shareholder yield	-19.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.56
1D price change	-1.01%
1M price change	2.08%
1M total return	2.08%
1W price change	4.26%
1W total return	4.26%
1Y price change	-12.5%
1Y return CAGR	-12.51%
1Y total return	-12.5%
20-day SMA	AUD 0.48
200-day SMA	AUD 0.60
3M price change	-5.77%
3M total return	-5.77%
3Y price change	2,233.33%
3Y return CAGR	185.69%
3Y total return	2,233.33%
50-day SMA	AUD 0.60
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 1.44
52-week high date	2026-01-08
52-week low	AUD 0.39
52-week low date	2026-07-14
5Y price change	92.16%
5Y return CAGR	13.96%
5Y total return	92.16%
6M price change	-6.67%
6M total return	-6.67%
All-time high	AUD 1.44
All-time high date	2026-01-08
All-time low	AUD 0.02
All-time low date	2024-02-20
Average true range (ATR)	AUD 0.04
Average volume	227.8K
Beta (1Y)	0.82
Beta (2Y)	0.6
Beta (5Y)	1.03
Change from 52-week high	-65.85%
Change from 52-week low	25.64%
Change from all-time high	-65.85%
Change from all-time low	2,622.22%
Change from open	-2%
Day's gap	1.01%
Dollar volume	AUD 59,755
High price	AUD 0.51
Low price	AUD 0.49
Monthly RSI	51.27
Open price	AUD 0.50
Position in 52-week range	0%
Previous close	AUD 0.50
Price vs 150-day SMA	-13.03%
Price vs 20-day SMA	2.51%
Price vs 200-day SMA	-18.17%
Price vs 50-day SMA	-17.9%
Relative volume	0.54
RSI	47.24
Sharpe ratio	0.22
Sharpe ratio (3Y)	0.89
Sharpe ratio (5Y)	0.53
Sortino ratio	0.42
Sortino ratio (3Y)	3.43
Sortino ratio (5Y)	1.74
Volume	121.9K
Weekly RSI	44.31
YTD price change	-56.25%
YTD total return	-56.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	126.1M
Shares change (QoQ)	3.94%
Shares change (YoY)	19.45%
Shares held by insiders	29.56%
Shares held by institutions	3.16%
Shares outstanding	247.6M

Deeper analysis on ASX/NYR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/NYR report

Is a complete ASX/NYR research report available?

No complete published report is available for asx/NYR (ASX/NYR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/NYR (ASX/NYR)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/NYR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/NYR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/NYR

Frequently asked questions